Vivos (RDGL) Interest Expenses (2010 - 2025)
Vivos (RDGL) reported Interest Expenses of $7.7 million for Q4 2025, up 4299.87% on a YoY basis from $174855.0 in Q4 2024, and up 6317.21% sequentially from $119887.0 in Q3 2025.
Vivos (RDGL) Interest Expenses (2010 - 2025) Analysis & Trends
Vivos (RDGL) has 16 years of Interest Expenses data on file, last reported at $7.7 million in Q4 2025.
- For the quarter ending Q4 2025, Interest Expenses rose 4299.87% year-over-year to $7.7 million; the trailing twelve-month figure through Dec 2025 stood at $7.7 million (up 4299.87% YoY), and the FY2025 full-year result was $7.7 million, up 5.92% from the prior year.
- Interest Expenses rose to $7.7 million in Q4 2025, from $119887.0 in the prior quarter.
- In the past five years, Interest Expenses ranged from a high of $7.7 million in Q4 2025 to a low of $6549.0 in Q1 2021.
- A 5-year average of $497064.2 and a median of $79224.0 in 2022 frame the typical range for Interest Expenses.
- Across the five-year window, Interest Expenses tumbled 97.27% in 2021 and jumped 4299.87% in 2025, its largest moves.
- Tracing RDGL's Interest Expenses over 5 years: stood at $31145.0 in 2021, then slumped by 48.52% to $16032.0 in 2022, then soared by 392.05% to $78886.0 in 2023, then jumped by 121.66% to $174855.0 in 2024, then jumped by 4299.87% to $7.7 million in 2025.
- Business Quant data shows RDGL's Interest Expenses at $7.7 million in Q4 2025, $119887.0 in Q3 2025, and $168773.0 in Q2 2025.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Interest Expense (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 183.73 Bn | 176.43 Bn | 6.27 Bn | 1.50 Bn |
| 2 | Stryker | 128.82 Bn | 125.94 Bn | 3.81 Bn | 148.00 Mn |
| 3 | Medtronic | 108.74 Bn | 99.52 Bn | 6.41 Bn | 142.00 Mn |
| 4 | Boston Scientific | 68.40 Bn | 66.95 Bn | 3.61 Bn | 512.00 Mn |
| 5 | Edwards Lifesciences | 47.42 Bn | 43.74 Bn | 1.29 Bn | 400.20 Mn |
| 6 | GE HealthCare Technologies | 28.47 Bn | 26.18 Bn | 1.98 Bn | 96.00 Mn |
| 7 | Dexcom | 28.42 Bn | 27.30 Bn | 750.30 Mn | 3.10 Mn |
| 8 | Smith & Nephew | 26.97 Bn | 26.40 Bn | - | -140.00 Mn |
| 9 | Koninklijke Philips | 25.52 Bn | 22.39 Bn | 2.07 Bn | -97.17 Mn |
| 10 | Vivos | 27.57 Mn | 26.01 Mn | -3,105.00 | 7.69 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 7.69 Mn |
| Dec 31, 2025 | 7.69 Mn |
| Sep 30, 2025 | 119,887.00 |
| Sep 30, 2025 | 119,887.00 |
| Jun 30, 2025 | 168,773.00 |
| Jun 30, 2025 | 168,773.00 |
| Mar 31, 2025 | 190,850.00 |
| Mar 31, 2025 | 190,850.00 |
| Dec 31, 2024 | 174,855.00 |
| Dec 31, 2024 | 174,855.00 |
| Sep 30, 2024 | 284,567.00 |
| Sep 30, 2024 | 284,567.00 |
| Jun 30, 2024 | 374,454.00 |
| Jun 30, 2024 | 374,454.00 |
| Mar 31, 2024 | 78,660.00 |
| Mar 31, 2024 | 78,660.00 |
| Dec 31, 2023 | 78,886.00 |
| Dec 31, 2023 | 78,886.00 |
| Sep 30, 2023 | 65,819.00 |
| Sep 30, 2023 | 65,819.00 |